Workflow
瑞康医药:股东拟减持不超过1%股份
RealcanRealcan(SZ:002589) news flash·2025-05-07 13:36

Group 1 - The core point of the article is that a major shareholder of Ruikang Pharmaceutical plans to reduce its stake by up to 1% of the total share capital [1] - The shareholder, Jingzhou Zhaoshang Huize Pharmaceutical Investment Partnership, intends to sell up to 15,047,105 shares through centralized bidding or block trading [1] - The reduction period is set to begin 15 trading days after the announcement and will last for three months [1] Group 2 - After the share reduction, Jingzhou Huize will no longer be a shareholder holding more than 5% of the company's shares [1]